INDUSTRY OVERVIEW
The Lung Cancer Surgery is Growing at 7.2% and is expected to reach 5.5Billion by 2030. Below mentioned are some of the dynamics shaping the Lung Cancer Surgery.Lung Cancer Surgery Market Size in (USD Billion) CAGR Growth Rate 7.2%
| Study Period | 2024-2030 |
| Market Size (2019): | 8Billion |
| Market Size (2030): | 5.5Billion |
| CAGR (2019 - 2030): | 7.2% |
| Fastest Growing Region | North America |
| Dominating Region | Asia-Pacific |
www.www.htfmarketinsights.com
Lung cancer surgery involves the removal of lung tissue, often as part of a treatment for lung cancer. Common procedures include lobectomy (removal of a lung lobe), pneumonectomy (removal of an entire lung), and video-assisted thoracic surgery (VATS). The market for lung cancer surgery is expanding due to rising lung cancer incidence and advancements in minimally invasive techniques.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report
Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
- Opportunities In Developing More Precise Surgical Methods
- Growth In Personalized Cancer Treatments
Market Restraints:
Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
- High Surgery Costs
- Risk Of Complications
- Need For Post-operative Care
Trends in the Market:
Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
- Rise of minimally invasive surgeries
- use of robotic surgery
Market Opportunities:
These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.
- Opportunities In Developing More Precise Surgical Methods
- Growth In Personalized Cancer Treatments
Check Out Prices
Get Price
Regulation Shaping the Healthcare Industry
The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.Major Regulatory Bodies Worldwide
1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization
SWOT Analysis in the Healthcare Industry
SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.• Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
• Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
• Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
• Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.
Market Segmentation
Segmentation by Type
- Lobectomy
- Pneumonectomy
Lung Cancer Surgery Market Segmentation by Type
www.htfmarketinsights.com
Segmentation by Application
- Oncology
- Surgical Procedures
- Hospitals
Lung Cancer Surgery Market Segmentation by Application
www.htfmarketinsights.com
Regional Outlook
The Asia-Pacific currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, North America is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, includingRegions
- North America
- LATAM
- West Europe
- Central & Eastern Europe
- Northern Europe
- Southern Europe
- East Asia
- Southeast Asia
- South Asia
- Central Asia
- Oceania
- MEA
Fastest Growing Region
North America
Dominating Region
Asia-Pacific
The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.
- 1. Intuitive Surgical (USA)
- 2. Medtronic (USA)
- 3. Siemens Healthineers (Germany)
- 4. Olympus Corporation (Japan)
- 5. Varian Medical Systems (USA)
- 6. Accuray Incorporated (USA)
- 7. Boston Scientific (USA)
- 8. Ethicon (USA)
- 9. Zimmer Biomet (USA)
- 10. Stryker Corporation (USA)
- 11. Brainlab (Germany)
- 12. AngioDynamics (USA)
- 13. Koninklijke Philips N.V. (Netherlands)
- 14. Karl Storz (Germany)
- 15. Canon Medical Systems (Japan)
- 16. Smith & Nephew (UK)
- 17. Cook Medical (USA)
- 18. AstraZeneca (UK)
- 19. Pfizer (USA)
Lung Cancer Surgery Market Segmentation by Players
www.htfmarketinsights.com
Primary and Secondary Research
Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.
Report Infographics
|
Report Features |
Details |
|
Base Year |
2019 |
|
Based Year Market Size (2023) |
8Billion |
|
Historical Period |
2024 to 2019 |
|
CAGR (2019 to 2030) |
7.2% |
|
Forecast Period |
2019 to 2030 |
|
Forecasted Period Market Size (2030) |
5.5Billion |
|
Scope of the Report |
Segmentation by Type Lobectomy, Pneumonectomy, Segmentation by Application Oncology, Surgical Procedures, Hospitals, Sales Channel |
|
Regions Covered |
North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA |
|
Companies Covered |
1. Intuitive Surgical (USA), 2. Medtronic (USA), 3. Siemens Healthineers (Germany), 4. Olympus Corporation (Japan), 5. Varian Medical Systems (USA), 6. Accuray Incorporated (USA), 7. Boston Scientific (USA), 8. Ethicon (USA), 9. Zimmer Biomet (USA), 10. Stryker Corporation (USA), 11. Brainlab (Germany), 12. AngioDynamics (USA), 13. Koninklijke Philips N.V. (Netherlands), 14. Karl Storz (Germany), 15. Canon Medical Systems (Japan), 16. Smith & Nephew (UK), 17. Cook Medical (USA), 18. AstraZeneca (UK), 19. Pfizer (USA) |
|
Customization Scope |
15% Free Customization (For EG) |
|
Delivery Format |
PDF and Excel through Email |
Lung Cancer Surgery - Table of Contents
Chapter 1: Market Preface
- 1.1 Global Lung Cancer Surgery Market Landscape
- 1.2 Scope of the Study
- 1.3 Relevant Findings & Stakeholder Advantages
Chapter 2: Strategic Overview
- 2.1 Global Lung Cancer Surgery Market Outlook
- 2.2 Total Addressable Market versus Serviceable Market
- 2.3 Market Rivalry Projection
Chapter 3 : Global Lung Cancer Surgery Market Business Environment & Changing Dynamics
-
3.1 Growth Drivers
- 3.1.1 Opportunities in developing more precise surgical methods
- 3.1.2 growth in personalized cancer treatments
-
3.2 Available Opportunities
- 3.2.1 Opportunities in developing more precise surgical methods
-
3.3 Influencing Trends
- 3.3.1 Rise of minimally invasive surgeries
- 3.3.2 use of robotic surg
-
3.4 Challenges
- 3.4.1 High surgery costs
- 3.4.2 risk of complications
- 3.4.3 need for post-
- 3.5 Regional Dynamics
Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Lung Cancer Surgery Industry Factors Assessment
- 4.1 Current Scenario
- 4.2 PEST Analysis
- 4.3 Business Environment - PORTER 5-Forces Analysis
- 4.3.1 Supplier Leverage
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of Substitutes
- 4.3.4 Threat from New Entrant
- 4.3.5 Market Competition Level
- 4.4 Roadmap of Lung Cancer Surgery Market
- 4.5 Impact of Macro-Economic Factors
- 4.6 Market Entry Strategies
- 4.7 Political and Regulatory Landscape
- 4.8 Supply Chain Analysis
- 4.9 Impact of Tariff War
Chapter 5: Lung Cancer Surgery : Competition Benchmarking & Performance Evaluation
- 5.1 Global Lung Cancer Surgery Market Concentration Ratio
- 5.1.1 CR4, CR8 and HH Index
- 5.1.2 % Market Share - Top 3
- 5.1.3 Market Holding by Top 5
- 5.2 Market Position of Manufacturers by Lung Cancer Surgery Revenue 2019
- 5.3 Global Lung Cancer Surgery Sales Volume by Manufacturers (2019)
- 5.4 BCG Matrix
- 5.4 Market Entropy
- 5.5 5C’s Analysis
- 5.6 Ansoff Matrix
Chapter 6: Global Lung Cancer Surgery Market: Company Profiles
- 6.1 1. Intuitive Surgical (USA)
- 6.1.1 1. Intuitive Surgical (USA) Company Overview
- 6.1.2 1. Intuitive Surgical (USA) Product/Service Portfolio & Specifications
- 6.1.3 1. Intuitive Surgical (USA) Key Financial Metrics
- 6.1.4 1. Intuitive Surgical (USA) SWOT Analysis
- 6.1.5 1. Intuitive Surgical (USA) Development Activities
- 6.2 2. Medtronic (USA)
- 6.3 3. Siemens Healthineers (Germany)
- 6.4 4. Olympus Corporation (Japan)
- 6.5 5. Varian Medical Systems (USA)
- 6.6 6. Accuray Incorporated (USA)
- 6.7 7. Boston Scientific (USA)
- 6.8 8. Ethicon (USA)
- 6.9 9. Zimmer Biomet (USA)
- 6.10 10. Stryker Corporation (USA)
- 6.11 11. Brainlab (Germany)
- 6.12 12. AngioDynamics (USA)
- 6.13 13. Koninklijke Philips N.V. (Netherlands)
- 6.14 14. Karl Storz (Germany)
- 6.15 15. Canon Medical Systems (Japan)
- 6.16 16. Smith & Nephew (UK)
- 6.17 17. Cook Medical (USA)
- 6.18 18. AstraZeneca (UK)
- 6.19 19. Pfizer (USA)
- 6.20 20. GE Healthcare (USA)
To View a Complete List of Players? Inquiry Now
Sectional Purchase
Chapter 7 : Global Lung Cancer Surgery by Type & Application (2024-2030)
-
7.1 Global Lung Cancer Surgery Market Revenue Analysis (USD Million) by Type (2024-2019)
- 7.1.1 Lobectomy
- 7.1.2 Pneumonectomy
- 7.1.3 Video-assisted Thoracic Surgery (VATS)
-
7.2 Global Lung Cancer Surgery Market Revenue Analysis (USD Million) by Application (2024-2019)
- 7.2.1 Oncology
- 7.2.2 Surgical Procedures
- 7.2.3 Hospitals
- 7.3 Global Lung Cancer Surgery Market Revenue Analysis (USD Million) by Type (2019-2030)
- 7.4 Global Lung Cancer Surgery Market Revenue Analysis (USD Million) by Application (2019-2030)
Chapter 8 : North America Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 8.1 North America Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 8.1.1 United States
- 8.1.2 Canada
-
8.2 North America Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 8.2.1 Lobectomy
- 8.2.2 Pneumonectomy
- 8.2.3 Video-assisted Thoracic Surgery (VATS)
-
8.3 North America Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 8.3.1 Oncology
- 8.3.2 Surgical Procedures
- 8.3.3 Hospitals
- 8.4 North America Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 8.5 North America Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 8.6 North America Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Looking for Section Purchase? Get Quote Now
Sectional Purchase
Chapter 9 : LATAM Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 9.1 LATAM Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 9.1.1 Brazil
- 9.1.2 Argentina
- 9.1.3 Chile
- 9.1.4 Mexico
- 9.1.5 Rest of LATAM
-
9.2 LATAM Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 9.2.1 Lobectomy
- 9.2.2 Pneumonectomy
- 9.2.3 Video-assisted Thoracic Surgery (VATS)
-
9.3 LATAM Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 9.3.1 Oncology
- 9.3.2 Surgical Procedures
- 9.3.3 Hospitals
- 9.4 LATAM Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 9.5 LATAM Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 9.6 LATAM Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 10 : West Europe Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 10.1 West Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 10.1.1 Germany
- 10.1.2 France
- 10.1.3 Benelux
- 10.1.4 Switzerland
- 10.1.5 Rest of West Europe
-
10.2 West Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 10.2.1 Lobectomy
- 10.2.2 Pneumonectomy
- 10.2.3 Video-assisted Thoracic Surgery (VATS)
-
10.3 West Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 10.3.1 Oncology
- 10.3.2 Surgical Procedures
- 10.3.3 Hospitals
- 10.4 West Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 10.5 West Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 10.6 West Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 11 : Central & Eastern Europe Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 11.1 Central & Eastern Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 11.1.1 Bulgaria
- 11.1.2 Poland
- 11.1.3 Hungary
- 11.1.4 Romania
- 11.1.5 Rest of CEE
-
11.2 Central & Eastern Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 11.2.1 Lobectomy
- 11.2.2 Pneumonectomy
- 11.2.3 Video-assisted Thoracic Surgery (VATS)
-
11.3 Central & Eastern Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 11.3.1 Oncology
- 11.3.2 Surgical Procedures
- 11.3.3 Hospitals
- 11.4 Central & Eastern Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 11.5 Central & Eastern Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 11.6 Central & Eastern Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 12 : Northern Europe Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 12.1 Northern Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 12.1.1 The United Kingdom
- 12.1.2 Sweden
- 12.1.3 Norway
- 12.1.4 Baltics
- 12.1.5 Ireland
- 12.1.6 Rest of Northern Europe
-
12.2 Northern Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 12.2.1 Lobectomy
- 12.2.2 Pneumonectomy
- 12.2.3 Video-assisted Thoracic Surgery (VATS)
-
12.3 Northern Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 12.3.1 Oncology
- 12.3.2 Surgical Procedures
- 12.3.3 Hospitals
- 12.4 Northern Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 12.5 Northern Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 12.6 Northern Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 13 : Southern Europe Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 13.1 Southern Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 13.1.1 Spain
- 13.1.2 Italy
- 13.1.3 Portugal
- 13.1.4 Greece
- 13.1.5 Rest of Southern Europe
-
13.2 Southern Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 13.2.1 Lobectomy
- 13.2.2 Pneumonectomy
- 13.2.3 Video-assisted Thoracic Surgery (VATS)
-
13.3 Southern Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 13.3.1 Oncology
- 13.3.2 Surgical Procedures
- 13.3.3 Hospitals
- 13.4 Southern Europe Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 13.5 Southern Europe Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 13.6 Southern Europe Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 14 : East Asia Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 14.1 East Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 14.1.1 China
- 14.1.2 Japan
- 14.1.3 South Korea
- 14.1.4 Taiwan
- 14.1.5 Others
-
14.2 East Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 14.2.1 Lobectomy
- 14.2.2 Pneumonectomy
- 14.2.3 Video-assisted Thoracic Surgery (VATS)
-
14.3 East Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 14.3.1 Oncology
- 14.3.2 Surgical Procedures
- 14.3.3 Hospitals
- 14.4 East Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 14.5 East Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 14.6 East Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 15 : Southeast Asia Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 15.1 Southeast Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 15.1.1 Vietnam
- 15.1.2 Singapore
- 15.1.3 Thailand
- 15.1.4 Malaysia
- 15.1.5 Indonesia
- 15.1.6 Philippines
- 15.1.7 Rest of SEA Countries
-
15.2 Southeast Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 15.2.1 Lobectomy
- 15.2.2 Pneumonectomy
- 15.2.3 Video-assisted Thoracic Surgery (VATS)
-
15.3 Southeast Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 15.3.1 Oncology
- 15.3.2 Surgical Procedures
- 15.3.3 Hospitals
- 15.4 Southeast Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 15.5 Southeast Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 15.6 Southeast Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 16 : South Asia Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 16.1 South Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 16.1.1 India
- 16.1.2 Bangladesh
- 16.1.3 Others
-
16.2 South Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 16.2.1 Lobectomy
- 16.2.2 Pneumonectomy
- 16.2.3 Video-assisted Thoracic Surgery (VATS)
-
16.3 South Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 16.3.1 Oncology
- 16.3.2 Surgical Procedures
- 16.3.3 Hospitals
- 16.4 South Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 16.5 South Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 16.6 South Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 17 : Central Asia Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 17.1 Central Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 17.1.1 Kazakhstan
- 17.1.2 Tajikistan
- 17.1.3 Others
-
17.2 Central Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 17.2.1 Lobectomy
- 17.2.2 Pneumonectomy
- 17.2.3 Video-assisted Thoracic Surgery (VATS)
-
17.3 Central Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 17.3.1 Oncology
- 17.3.2 Surgical Procedures
- 17.3.3 Hospitals
- 17.4 Central Asia Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 17.5 Central Asia Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 17.6 Central Asia Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 18 : Oceania Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 18.1 Oceania Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 18.1.1 Australia
- 18.1.2 New Zealand
- 18.1.3 Others
-
18.2 Oceania Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 18.2.1 Lobectomy
- 18.2.2 Pneumonectomy
- 18.2.3 Video-assisted Thoracic Surgery (VATS)
-
18.3 Oceania Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 18.3.1 Oncology
- 18.3.2 Surgical Procedures
- 18.3.3 Hospitals
- 18.4 Oceania Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 18.5 Oceania Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 18.6 Oceania Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 19 : MEA Lung Cancer Surgery Market Breakdown by Country, Type & Application
- 19.1 MEA Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2024-2019]
- 19.1.1 Turkey
- 19.1.2 South Africa
- 19.1.3 Egypt
- 19.1.4 UAE
- 19.1.5 Saudi Arabia
- 19.1.6 Israel
- 19.1.7 Rest of MEA
-
19.2 MEA Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2024-2019]
- 19.2.1 Lobectomy
- 19.2.2 Pneumonectomy
- 19.2.3 Video-assisted Thoracic Surgery (VATS)
-
19.3 MEA Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2024-2019]
- 19.3.1 Oncology
- 19.3.2 Surgical Procedures
- 19.3.3 Hospitals
- 19.4 MEA Lung Cancer Surgery Market by Country (USD Million) & Sales Volume (Units) [2020-2030]
- 19.5 MEA Lung Cancer Surgery Market by Type (USD Million) & Sales Volume (Units) [2020-2030]
- 19.6 MEA Lung Cancer Surgery Market by Application (USD Million) & Sales Volume (Units) [2020-2030]
Chapter 20: Research Findings & Conclusion
- 20.1 Key Findings
- 20.2 Conclusion
Chapter 21: Methodology and Data Source
-
21.1 Research Methodology & Approach
- 21.1.1 Research Program/Design
- 21.1.2 Market Size Estimation
- 21.1.3 Market Breakdown and Data Triangulation
-
21.2 Data Source
- 21.2.1 Secondary Sources
- 21.2.2 Primary Sources
Chapter 22: Appendix & Disclaimer
- 22.1 Acronyms & bibliography
- 22.2 Disclaimer
Frequently Asked Questions (FAQ):
The Lung Cancer Surgery market is estimated to derive a market size of 5.5 billion by 2030.
The Lung Cancer Surgery Market is estimated to grow at a CAGR of 7.2%, currently pegged at 8 Billion.
The changing dynamics and trends such as Rise Of Minimally Invasive Surgeries, Use Of Robotic Surgery, Advancements In Pre-surgical Screening And Diagnostics are seen as major Game Changer in Global Lung Cancer Surgery Market.
- Opportunities In Developing More Precise Surgical Methods
- Growth In Personalized Cancer Treatments
- Expanding Access To Surgery In Developing Regions
Business transformation in Lung Cancer Surgery Market has taken hold due to the confluence of several important triggers, some of them are High Surgery Costs, Risk Of Complications, Need For Post-operative Care, Surgical Skill Requirements.
The market opportunity is clear from the flow of investment into Global Lung Cancer Surgery Market, some of them are Opportunities In Developing More Precise Surgical Methods, Growth In Personalized Cancer Treatments, Expanding Access To Surgery In Developing Regions.
Lung Cancer Surgery Market identifies market share by players along with the concentration rate using CR4, CR8 Index to determine leading and emerging competitive players such as 1. Intuitive Surgical (USA), 2. Medtronic (USA), 3. Siemens Healthineers (Germany), 4. Olympus Corporation (Japan), 5. Varian Medical Systems (USA), 6. Accuray Incorporated (USA), 7. Boston Scientific (USA), 8. Ethicon (USA), 9. Zimmer Biomet (USA), 10. Stryker Corporation (USA), 11. Brainlab (Germany), 12. AngioDynamics (USA), 13. Koninklijke Philips N.V. (Netherlands), 14. Karl Storz (Germany), 15. Canon Medical Systems (Japan), 16. Smith & Nephew (UK), 17. Cook Medical (USA), 18. AstraZeneca (UK), 19. Pfizer (USA), 20. GE Healthcare (USA).
The Global Lung Cancer Surgery Market Study is Broken down by applications such as Oncology, Surgical Procedures, Hospitals.
The Global Lung Cancer Surgery Market Study is segmented by Lobectomy, Pneumonectomy, Video-assisted Thoracic Surgery (VATS).
The Global Lung Cancer Surgery Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA
Historical Year: 2024 - Base year: 2019. Forecast period**: 2025 to 2030 [** unless otherwise stated]
Lung cancer surgery involves the removal of lung tissue, often as part of a treatment for lung cancer. Common procedures include lobectomy (removal of a lung lobe), pneumonectomy (removal of an entire lung), and video-assisted thoracic surgery (VATS). The market for lung cancer surgery is expanding due to rising lung cancer incidence and advancements in minimally invasive techniques.
